Role of mycophenolate mofetil in the treatment of autoimmune hepatitis

Journal of Hepatology

Volumn 55, Issue 3, 2011, Pages 510-511

  Schramm, Christoph ^a   Lohse, Ansgar W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ANCA ASSOCIATED VASCULITIS; AUTOIMMUNE HEPATITIS; CHOLESTATIC HEPATITIS; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; EDITORIAL; GASTROINTESTINAL SYMPTOM; HUMAN; MONOTHERAPY; NEUTROPENIA; PANCREATITIS; PRIORITY JOURNAL; PSYCHOSIS; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID;

EID: 84860423721     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.01.012     Document Type: Editorial

References (20)

1. M.P. Manns, A.J. Czaja, J.D. Gorham, E.L. Krawitt, G. Mieli-Vergani, and D. Vergani Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
2. Lohse AW, Mieli-Vergani G. Autoimmune Hepatitis. J Hepatol 2010 [Epub ahead of print].
3. S. Kanzler, H. Lohr, G. Gerken, P.R. Galle, and A.W. Lohse Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience Z Gastroenterol 39 2001 339 341 344-338
4. T. Al-Chalabi, J.A. Underhill, B.C. Portmann, I.G. McFarlane, and M.A. Heneghan Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis J Hepatol 48 2008 140 147 (Pubitemid 350191991)
5. J.S. Bajaj, K. Saeian, R.R. Varma, J. Franco, J.F. Knox, and J. Podoll Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience Am J Gastroenterol 100 2005 1121 1125 (Pubitemid 40769051)
6. M.P. Manns, M. Woynarowski, W. Kreisel, Y. Lurie, C. Rust, and E. Zuckerman Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis Gastroenterology 139 2010 1198 1206
7. K. Zachou, N. Gatselis, G. Papadamou, E. Rigopoulou, and G. Dalekos Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients J Hepatol 55 2011 636 646
8. A.C. Allison, and E.M. Eugui Mycophenolate mofetil and its mechanisms of action Immunopharmacology 47 2000 85 118 (Pubitemid 30394534)
9. A. Bardsley-Elliot, S. Noble, and R.H. Foster Mycophenolate mofetil: a review of its use in the management of solid organ transplantation BioDrugs 12 1999 363 410
10. G. Opelz, and B. Dohler Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation Transplantation 87 2009 795 802
11. G. Germani, M. Pleguezuelo, F. Villamil, S. Vaghjiani, E. Tsochatzis, and L. Andreana Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil Am J Transplant 9 2009 1725 1731
12. L. Iaccarino, M. Rampudda, M. Canova, S. Della Libera, P. Sarzi-Puttinic, and A. Doria Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 6 2007 190 195 (Pubitemid 46187338)
13. T.F. Hiemstra, M. Walsh, A. Mahr, C.O. Savage, K. de Groot, and L. Harper Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial JAMA 304 2010 2381 2388
14. J.T. Hlivko, M.L. Shiffman, R.T. Stravitz, V.A. Luketic, A.J. Sanyal, and M. Fuchs A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis Clin Gastroenterol Hepatol 6 2008 1036 1040
15. E.M. Hennes, Y.H. Oo, C. Schramm, U. Denzer, P. Buggisch, and C. Wiegard Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol 103 2008 1 8
16. M. Werner, S. Wallerstedt, S. Lindgren, S. Almer, E. Bjornsson, and A. Bergquist Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response Scand J Gastroenterol 45 2010 457 467
17. S. Luth, J. Herkel, S. Kanzler, C. Frenzel, P.R. Galle, and H.P. Dienes Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis J Clin Gastroenterol 42 2008 926 930
18. M.A. Heneghan, T. Al-Chalabi, and I.G. McFarlane Cost-effectiveness of pharmacotherapy for autoimmune hepatitis Expert Opin Pharmacother 7 2006 145 156
19. J.P. Gisbert Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding Inflamm Bowel Dis 16 2010 881 895
20. K. Sharzehi, M.A. Huang, I.R. Schreibman, and K.A. Brown Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy Can J Gastroenterol 24 2010 588 592